Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Bronchiolitis
  • Respiratory Disease
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: single site, prospective, randomizedMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 18 years
Gender
Both males and females

Description

Bronchiolitis is common infection in the small airways of the lungs in the pediatric population. It typically affects children under the age of two years during the fall and winter months.Infants with this condition often have a significant amount of nasal drainage and congestion. Infants are known ...

Bronchiolitis is common infection in the small airways of the lungs in the pediatric population. It typically affects children under the age of two years during the fall and winter months.Infants with this condition often have a significant amount of nasal drainage and congestion. Infants are known to be obligate nasal breathers. When the nasal secretions block the nasal airway, then breathing, sleeping, and eating/drinking all become very difficult. For this reason it is very important to have a good method of suctioning out the nose and clearing out the secretions. Historically a baby's nose was suctioned with a bulb syringe. These are still commonly used and are given out in the hospital setting, although there are many other types of devices that have been developed recently that are used for suctioning. One of these devices that has become very common among parents now is called the NoseFrida. It is important to evaluate this device and its efficacy compared to the bulb syringe. Parents/guardians of eligible caregivers will be approached for informed consent. Those who consent will then be supplied with a suction device to be used once their child is discharged home: either a NoseFrida device or a bulb syringe. The device supplied will be dependent on the week of enrollment in the study (the investigators will rotate supplying NoseFrida to all patients one week, and bulb syringe to all patients the next week in order to attain similar size cohorts). Education will be given to caregivers on how to use their respective suction device. Along with the device, a form (Home monitoring form) will be supplied that will outline what should be monitored while using the device. At 7 days after discharge from the Emergency Center, caregivers will complete a survey asking questions about their baby's condition over the past week.

Tracking Information

NCT #
NCT04599101
Collaborators
Fridababy
Investigators
Principal Investigator: Margaret J Menoch Beaumont